Skip to search formSkip to main contentSkip to account menu

Fluosol-DA

Known as: FSOL 
A perfluorocarbon blood substitute in trials for the treatment of severe anemia
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
ABSTRACT Adenoviral vectors (AdV) have received considerable attention for vaccine development because of their high… 
1994
1994
The stability of the first generation of injectable fluorocarbon-based oxygen-carriers, exemplified by Fluosol® (Green Cross Corp… 
Highly Cited
1989
Highly Cited
1988
Highly Cited
1988
The administration of a perfluorochemical emulsion and carbogen (95% O2, 5% CO2) breathing before photodynamic therapy (PDT) was… 
Highly Cited
1987
Highly Cited
1987
Fluosol-DA with carbogen (95% oxygen and 5% carbon dioxide) breathing can increase the efficacy of melphalan. Addition of Fluosol… 
Highly Cited
1987
Highly Cited
1986
Highly Cited
1986
Abstract We assessed the safety and efficacy of Fluosol-DA as a red-cell substitute in acute anemia. Twenty-three surgical… 
Highly Cited
1982
Highly Cited
1982
After the experimental and phase one studies of our so-called "artificial blood," Fluosol-DA (20%), an emulsified mixture of… 
Highly Cited
1981
Highly Cited
1981
Fluosol-DA (Perfluorochemlcal Blood Substitutes) are small particle fluorocarbons suspended in an emulsion and have a high… 
Highly Cited
1980
Highly Cited
1980
Cardiorespiratory measurements were made in a severely anemic patient (hemoglobin concentration of 3.5 g/dl) who was…